Tag: 21st.BIO

21st.BIO targets key infant nutrition protein

21st.BIO targets key infant nutrition protein

July 14, 2025 |

In Denmark, precision fermentation firm 21st.BIOhas launched a development program for bovine alpha-lactalbumin (α-lac) after exclusively licensing the high-yield microbial strain from Novonesis. Alpha-lactalbumin is a highly functional milk protein rich in essential amino acids. It is easy to digest and is linked to immune and cognitive development benefits. Bovine α-lac is currently used in […]

Read More